Literature DB >> 28691596

The relationship between the INTERMED patient complexity instrument and Level of Care Utilisation System (LOCUS).

Steven Thurber1, Ann Wilson2, George Realmuto2, Sheila Specker2.   

Abstract

OBJECTIVE: To investigate the concurrent and criterion validity of two independently developed measurement instruments, INTERMED and LOCUS, designed to improve the treatment and clinical management of patients with complex symptom manifestations.
METHODS: Participants (N = 66) were selected from hospital records based on the complexity of presenting symptoms, with tripartite diagnoses across biological, psychiatric and addiction domains. Biopsychosocial information from hospital records were submitted to INTERMED and LOCUS grids. In addition, Global Assessment of Functioning (GAF) ratings were gathered for statistical analyses.
RESULTS: The product moment correlation between INTERMED and LOCUS was 0.609 (p = .01). Inverse zero-order correlations for INTERMED and LOCUS total score and GAF were obtained. However, only the beta weight for LOCUS and GAF was significant. An exploratory principal components analysis further illuminated areas of convergence between the instruments.
CONCLUSIONS: INTERMED and LOCUS demonstrated shared variance. INTERMED appeared more sensitive to complex medical conditions and severe physiological reactions, whereas LOCUS findings are more strongly related to psychiatric symptoms. Implications are discussed.

Entities:  

Keywords:  Adult psychiatry; biopsychosocial; clinical assessment; community mental health services

Mesh:

Year:  2017        PMID: 28691596     DOI: 10.1080/13651501.2017.1353635

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  1 in total

1.  BMI Course Over 10 Years After Bariatric Surgery and Biopsychosocial Complexity Assessed with the INTERMED: a Retrospective Study.

Authors:  Yann Corminboeuf; Beate Wild; Catherine Zdrojewski; Dieter Schellberg; Lucie Favre; Michel Suter; Friedrich Stiefel
Journal:  Obes Surg       Date:  2021-05-12       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.